Whether this mechanism, likely in concert with other inflammatory stimuli present within the tumor microenvironment, plays a role in the selective loss of foxp3 observed in tumor-infiltrating Tregs is currently under investigation. The gene discussed is FOXP3; the disease is neoplasm.